Interest in the effects of hormone therapy on health outcomes among
postmenopausal women has perhaps never been greater. As recently reported,1 the Women's Health Initiative (WHI) randomized clinical
trial of postmenopausal hormone therapy terminated the combined estrogen-progestin
arm (but not the estrogen-only arm) early after an average follow-up of 5.2
years (planned duration, 8.5 years).2 Women
who received estrogen plus progestin experienced a small but significant increase
in the primary outcome, coronary heart disease; a nonsignificant trend toward
an increase in the primary adverse outcome, invasive breast cancer; and a
significant increase in a global index (which included the 2 primary outcomes
plus stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip
fracture, and death due to other causes) summarizing risk and benefit. However,
the decision to stop this portion of the trial did not take into account several
other important outcomes that may affect a woman's choice of whether to take
hormone therapy, including potential effects on cognition. Two ancillary studies
to the WHI randomized trial focus on risk of dementia and cognitive decline,
but these outcomes are not considered in the WHI risk-benefit profile.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 126
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Although the logic of prognostic balance is clear in comparing hospitalized patients with those...
Users' Guides to the Medical Literature
What was the cause of bias in the HRT observational studies? Evidence suggests that women...
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.